Valuation: JBCHEMICAPAR

Market Cap 39TCr 404.78Cr 346.57Cr 323.35Cr 296.71Cr 557.53Cr 568.51Cr 3.84TCr 1.5TCr 19TCr 1.52TCr 1.49TCr 64TCr P/E 2027 *
43.3x
P/E 2028 * 33x
Enterprise Value 39TCr 404.78Cr 346.57Cr 323.35Cr 296.71Cr 557.53Cr 568.51Cr 3.84TCr 1.5TCr 19TCr 1.52TCr 1.49TCr 64TCr EV / Sales 2027 *
8.14x
EV / Sales 2028 * 7.12x
Free-Float
-
Yield 2027 *
0.72%
Yield 2028 * 0.86%
1 day-3.73%
3 months+10.95%
6 months+21.26%
Current year+32.51%
Current year 1,777.05
Extreme 1777.05
2,509.4
1 year 1,603.05
Extreme 1603.05
2,509.4
3 years 1,246.05
Extreme 1246.05
2,509.4
5 years 669.52
Extreme 669.525
2,509.4
10 years 118
Extreme 118
2,509.4
Date Insider Type Main position Quantity % Market Cap.
22/09/25 Sell

Chief Executive Officer

24,785 0.0159%
22/09/25 Sell

Chief Executive Officer

19,312 0.0124%
15/09/25 Sell

Chief Executive Officer

965 0.0006%

Financials

2027 *2028 *
Net sales 4.76TCr 50Cr 43Cr 40Cr 36Cr 69Cr 70Cr 471.49Cr 183.8Cr 2.39TCr 186.81Cr 182.74Cr 7.9TCr 5.44TCr 57Cr 49Cr 45Cr 42Cr 78Cr 80Cr 538.88Cr 210.07Cr 2.73TCr 213.51Cr 208.86Cr 9.03TCr
Net income 899.73Cr 9.4Cr 8.05Cr 7.51Cr 6.89Cr 13Cr 13Cr 89Cr 35Cr 450.91Cr 35Cr 35Cr 1.49TCr 1.19TCr 12Cr 11Cr 9.9Cr 9.08Cr 17Cr 17Cr 117.41Cr 46Cr 594.08Cr 47Cr 46Cr 1.97TCr
Net Debt - -
Logo JBCHEMICAPAR
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.
Employees
5,602
Sector
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2,412.25INR
Average target price
2,328.14INR
Spread / Average Target
-3.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. JBCHEPHARM Stock